Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivani Medical, Inc.VANI · Entity 6636 | Director | June 24, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivani Medical, Inc.
Report date June 24, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2036-06-23 | Direct | 36,516 |
Reported balance
After 2026-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-24 · Grant · Acquired 36,516 · Balance 36,516 F2: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
F2: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Jun 25, 2026 23:40 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 36,516 | $1.22 Strike: $1.22 | $44,549.52 |
DisclosureSEC source: 0001753926-26-001070 · form4.xml · derivative · entry 1 Popoff Alexandra L. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,516 Underlying: Common Stock · 36,516 shares Expires 2036-06-23 F2 · price: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · derivative.underlying_shares: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 23:15 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 35,135 | $1.27 Strike: $1.27 | $44,621.45 |
DisclosureSEC source: 0001753926-25-001024 · form4.xml · derivative · entry 1 Popoff Alexandra L. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,135 Underlying: Common Stock · 35,135 shares Expires 2035-06-23 F2 · price: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · derivative.underlying_shares: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 20:47 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 34,839 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-24-001191 · ownership.xml · derivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,839 Underlying: Common Stock · 34,839 shares Expires 2034-06-26 F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 23:29 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 32,121 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001753926-23-000813 · form_4.xml · derivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,121 Underlying: Common Stock · 32,121 shares Expires 2033-06-15 F2 · derivative.exercise_date: Options vest monthly over a one-year period. F1 · balance_after: Awarded as compensation for serving on the Board of Directors. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 23:11 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock | 1,967 | $1.05 | $2,065.35 |
DisclosureSEC source: 0001753926-23-000483 · ownership.xml · nonDerivative · entry 2 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,166 F1 · price: Shares acquired in open market transaction Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 23:11 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock | 33 | $1.05 | $34.65 |
DisclosureSEC source: 0001753926-23-000483 · ownership.xml · nonDerivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199 F1 · price: Shares acquired in open market transaction Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 22:57 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,387 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0001753926-22-001278 · ownership.xml · derivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,387 Underlying: Common Stock · 17,387 shares Expires 2032-09-14 F1 · derivative.exercise_date: The stock options have a 10-year term and vest monthly equally over three years. F2 · derivative.underlying_shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 17:08 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 500 | $6.23 | $3,112.50 |
DisclosureSEC source: 0001209191-21-039403 · doc4.xml · nonDerivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · price: Shares acquired in open market transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.